Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma

MLA

Zhenjun Yu, et al. “Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.” Frontiers in Oncology, vol. 11, Oct. 2021. EBSCOhost, https://doi.org/10.3389/fonc.2021.755814.

APA

Zhenjun Yu, Yu Zhang, Shuai Shao, Qi Liu, Yuhan Li, Xiaoxiao Du, Kun Zhang, Mengxia Zhang, Haixia Yuan, Qiang Yuan, Tong Liu, Yingtang Gao, Yijun Wang, Wei Hong, & Tao Han. (2021). Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.755814

Chicago

Zhenjun Yu, Yu Zhang, Shuai Shao, Qi Liu, Yuhan Li, Xiaoxiao Du, Kun Zhang, et al. 2021. “Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.” Frontiers in Oncology 11 (October). doi:10.3389/fonc.2021.755814.